Tissue Sealants Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Tissue Sealants Pipeline Market Report Overview

Tissue sealants serve primarily as a physical barrier to prevent leakage of fluid and/or gas from a surgical incision. The tissue sealants pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segments ·       Synthetic Tissue Sealants

·       Fibrin Based Tissue Sealants

·       Fibrin-Based Tissue Sealants in Liquid Form

·       Other Protein-based Tissue Sealants

Key Territories ·       The United States

·       The United Kingdom

·       Europe

·       Israel

·       South Korea

Key Regulatory Paths ·       510(k)

·       PMA

·       CE

·       MDITAC

·       MDL

Leading Companies ·       Advanced Medical Solutions Group plc

·       Aleo BME Inc

·       Aleo BME Inc

·       Angiotech Pharmaceuticals Inc

·       Arch Therapeutics Inc

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Tissue Sealants Pipeline Market Segments

The key segments in the tissue sealants pipeline market are synthetic tissue sealants, fibrin based tissue sealants, fibrin-based tissue sealants in liquid form, and other protein-based tissue sealants. As of October 2024, the synthetic sealents segment contributes to the highest tissue sealants pipeline market share.

Tissue Sealants Pipeline Market Analysis by Segments, 2024 (%)

Tissue Sealants Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segment Insights into the Tissue Sealants Pipeline Market or Download a Free Report Sample

Tissue Sealants Pipeline Market Segmentation by Territories

A few of the key territories with the tissue sealants pipeline market are the United States, the United Kingdom, Europe, Israel, South Korea, and others. As of October 2024, the US accounted for the highest number of pipeline products.

Tissue Sealants Pipeline Market Analysis by Territories, 2024 (%)

Tissue Sealants Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Tissue Sealants Pipeline Market or Download a Free Report Sample

Tissue Sealants Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the tissue sealants pipeline products market are 510(k), PMA, CE, MDITAC, MDL, and others. As of October 2024, 510(k) was the most followed pathway for pipeline products in the tissue sealants market.

Tissue Sealants Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Tissue Sealants Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Tissue Sealants Pipeline Market or Download a Free Report Sample

Tissue Sealants Pipeline Market – Competitive Landscape

A few of the key companies associated with the tissue sealants pipeline market are Advanced Medical Solutions Group plc, Aleo BME Inc, Aleo BME Inc, Angiotech Pharmaceuticals Inc, Arch Therapeutics Inc, and others.

Advanced Medical Solutions Group Plc (AMS): Headquartered in Winsford, Cheshire, the UK, Advanced Medical Solutions Group Plc (AMS) is a medical technology company. It designs, manufactures, and distributes wound care dressings and medical adhesives for closing wounds and sealing tissues. The company develops products utilizing a wide range of technology platforms.

Angiotech Pharmaceuticals Inc: Headquartered in Vancouver, British Columbia, Canada, Angiotech Pharmaceuticals Inc is a surgical specialist corporation that offers medical devices. The company provides ophthalmology medicine, plastic surgery medicine, orthopedics medicine, urology medicine, dental medicine, veterinary medicine, and private-label finished goods, among others

Tissue Sealants Pipeline Market Analysis by Companies, 2024

Tissue Sealants Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Tissue Sealants Pipeline Market or Download a Free Report Sample

Segments Covered in the Report

Tissue Sealants Pipeline Market Segments Outlook (2024)

  • Synthetic Tissue Sealants
  • Fibrin Based Tissue Sealants
  • Fibrin-Based Tissue Sealants in Liquid Form
  • Other Protein-based Tissue Sealants

Tissue Sealants Pipeline Market Territories Outlook (2024)

  • United States
  • Global
  • Europe
  • Israel
  • South Korea

Tissue Sealants Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • PMA
  • CE
  • MDITAC
  • MDL

Scope

This report provides:

  • Extensive coverage of the tissue sealants under development.
  • An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of tissue sealants and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of tissue sealants under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Advanced Medical Solutions Group plc
Aleo BME Inc
Angiotech Pharmaceuticals Inc
Arch Therapeutics Inc
Arizona State University
Baxter International Inc
Biomedica Management Corp
Boston University
Calmare Therapeutics Inc
Clemson University
Cohera Medical Inc
Covalent Medical, Inc. (Inactive)
CR Bard Inc
Department of Biomedical Engineering Columbia University
DSM Biomedical BV
Elastagen Pty Ltd
Empa
Ethicon Endo-Surgery Inc
Gamma Diagnostics Inc
GATT Technologies BV
Hemostasis LLC
HyperBranch Medical Technology Inc
Institute of Molecular Biology of Parana
InVivo Therapeutics Corp
Johns Hopkins University
Kollodis BioSciences Inc
Kuros Biosciences AG
Laser Tissue Welding, Inc.
Medisse BV (Inactive)
Meril Life Sciences Pvt Ltd
Nurami Medical Ltd
Pharming Group NV
Polyganics BV
Protein Polymer Technologies Inc (Inactive)
Purdue University
Samyang Biopharmaceuticals Corp
SCL Science Inc
Sea Run Holdings Inc
Sealantis Ltd.
Sealonix Inc
Selio Medical
Shanghai Haohai Biological Technology Co Ltd
Surgical Sealants, Inc.
Teijin Pharma Ltd
Terasaki Institute for Biomedical Innovation
Tetratherix Pty Ltd
Texas A&M Engineering Experiment Station
Texas A&M University
The Medicines Co
Tissium SA
University of Akron

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Tissue Sealants Overview

3 Products under Development

3.1 Tissue Sealants – Pipeline Products by Stage of Development

3.2 Tissue Sealants – Pipeline Products by Segment

3.3 Tissue Sealants – Pipeline Products by Territory

3.4 Tissue Sealants – Pipeline Products by Regulatory Path

3.5 Tissue Sealants – Pipeline Products by Estimated Approval Date

4 Tissue Sealants – Pipeline Products under Development by Companies

4.1 Tissue Sealants Companies – Pipeline Products by Stage of Development

4.2 Tissue Sealants – Pipeline Products by Stage of Development

5 Tissue Sealants Companies and Product Overview

5.1 Advanced Medical Solutions Group plc Company Overview

5.1.1 Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview

5.2 Aleo BME Inc Company Overview

5.2.1 Aleo BME Inc Pipeline Products & Ongoing Clinical Trials Overview

5.3 Angiotech Pharmaceuticals Inc Company Overview

5.3.1 Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.4 Arch Therapeutics Inc Company Overview

5.4.1 Arch Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.5 Arizona State University Company Overview

5.5.1 Arizona State University Pipeline Products & Ongoing Clinical Trials Overview

5.6 Baxter International Inc Company Overview

5.6.1 Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview

5.7 Biomedica Management Corp Company Overview

5.7.1 Biomedica Management Corp Pipeline Products & Ongoing Clinical Trials Overview

5.8 Boston University Company Overview

5.8.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview

5.9 Calmare Therapeutics Inc Company Overview

5.9.1 Calmare Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.10 Clemson University Company Overview

5.10.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview

5.11 Cohera Medical Inc Company Overview

5.11.1 Cohera Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.12 Covalent Medical, Inc. (Inactive) Company Overview

5.12.1 Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.13 CR Bard Inc Company Overview

5.13.1 CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview

5.14 Department of Biomedical Engineering Columbia University Company Overview

5.14.1 Department of Biomedical Engineering Columbia University Pipeline Products & Ongoing Clinical Trials Overview

5.15 DSM Biomedical BV Company Overview

5.15.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview

5.16 Elastagen Pty Ltd Company Overview

5.16.1 Elastagen Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.17 Empa Company Overview

5.17.1 Empa Pipeline Products & Ongoing Clinical Trials Overview

5.18 Ethicon Endo-Surgery Inc Company Overview

5.18.1 Ethicon Endo-Surgery Inc Pipeline Products & Ongoing Clinical Trials Overview

5.19 Gamma Diagnostics Inc Company Overview

5.19.1 Gamma Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.20 GATT Technologies BV Company Overview

5.20.1 GATT Technologies BV Pipeline Products & Ongoing Clinical Trials Overview

5.21 Hemostasis LLC Company Overview

5.21.1 Hemostasis LLC Pipeline Products & Ongoing Clinical Trials Overview

5.22 HyperBranch Medical Technology Inc Company Overview

5.22.1 HyperBranch Medical Technology Inc Pipeline Products & Ongoing Clinical Trials Overview

5.23 Institute of Molecular Biology of Parana Company Overview

5.23.1 Institute of Molecular Biology of Parana Pipeline Products & Ongoing Clinical Trials Overview

5.24 InVivo Therapeutics Corp Company Overview

5.24.1 InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview

5.25 Johns Hopkins University Company Overview

5.25.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview

5.26 Kollodis BioSciences Inc Company Overview

5.26.1 Kollodis BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview

5.27 Kuros Biosciences AG Company Overview

5.27.1 Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview

5.28 Laser Tissue Welding, Inc. Company Overview

5.28.1 Laser Tissue Welding, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.29 Medisse BV (Inactive) Company Overview

5.29.1 Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.30 Meril Life Sciences Pvt Ltd Company Overview

5.30.1 Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.31 Nurami Medical Ltd Company Overview

5.31.1 Nurami Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.32 Pharming Group NV Company Overview

5.32.1 Pharming Group NV Pipeline Products & Ongoing Clinical Trials Overview

5.33 Polyganics BV Company Overview

5.33.1 Polyganics BV Pipeline Products & Ongoing Clinical Trials Overview

5.34 Protein Polymer Technologies Inc (Inactive) Company Overview

5.34.1 Protein Polymer Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.35 Purdue University Company Overview

5.35.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview

5.36 Samyang Biopharmaceuticals Corp Company Overview

5.36.1 Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview

5.37 SCL Science Inc Company Overview

5.37.1 SCL Science Inc Pipeline Products & Ongoing Clinical Trials Overview

5.38 Sea Run Holdings Inc Company Overview

5.38.1 Sea Run Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview

5.39 Sealantis Ltd. Company Overview

5.39.1 Sealantis Ltd. Pipeline Products & Ongoing Clinical Trials Overview

5.40 Sealonix Inc Company Overview

5.40.1 Sealonix Inc Pipeline Products & Ongoing Clinical Trials Overview

5.41 Selio Medical Company Overview

5.41.1 Selio Medical Pipeline Products & Ongoing Clinical Trials Overview

5.42 Shanghai Haohai Biological Technology Co Ltd Company Overview

5.42.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.43 Surgical Sealants, Inc. Company Overview

5.43.1 Surgical Sealants, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.44 Teijin Pharma Ltd Company Overview

5.44.1 Teijin Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.45 Terasaki Institute for Biomedical Innovation Company Overview

5.45.1 Terasaki Institute for Biomedical Innovation Pipeline Products & Ongoing Clinical Trials Overview

5.46 Tetratherix Pty Ltd Company Overview

5.46.1 Tetratherix Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.47 Texas A&M Engineering Experiment Station Company Overview

5.47.1 Texas A&M Engineering Experiment Station Pipeline Products & Ongoing Clinical Trials Overview

5.48 Texas A&M University Company Overview

5.48.1 Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview

5.49 The Medicines Co Company Overview

5.49.1 The Medicines Co Pipeline Products & Ongoing Clinical Trials Overview

5.50 Tissium SA Company Overview

5.50.1 Tissium SA Pipeline Products & Ongoing Clinical Trials Overview

5.51 University of Akron Company Overview

5.51.1 University of Akron Pipeline Products & Ongoing Clinical Trials Overview

6 Tissue Sealants- Recent Developments

6.1 Sep 09, 2024: Baxter Names Former Auto Exec Jay Craig to Its Board

6.2 Sep 05, 2024: Johnson & Johnson Appoints Christian Rodseth as North Asia Managing Director

6.3 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.4 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.5 Aug 26, 2024: Johnson & Johnson Taps New Chief Human Resources Officer

6.6 Jul 31, 2024: Asahi Kasei Releases Results for Q1 Fiscal 2024

6.7 Jul 17, 2024: Baxter to Host Second-Quarter 2024 Financial Results Conference Call for Investors

6.8 Jun 13, 2024: Medtronic Confirms Global Layoffs

6.9 Jun 04, 2024: Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results

6.10 May 07, 2024: Baxter to Present at Bank of America 2024 Health Care Conference

6.11 Apr 22, 2024: Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)

6.12 Apr 02, 2024: Johnson & Johnson to Participate in the BofA Securities Health Care Conference

6.13 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference

6.14 Feb 14, 2024: Johnson & Johnson to Participate in the Barclays 26th Annual Global Healthcare Conference

6.15 Jan 04, 2024: Baxter to Host Fourth-Quarter 2023 Financial Results Conference Call for Investors

6.16 Dec 07, 2023: Johnson & Johnson to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

6.17 Nov 08, 2023: ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update

6.18 Nov 07, 2023: Asahi Kasei Announces Consolidated Results for 1st and 2nd Quarter Fiscal 2023: April 1, 2023 – September 30, 2023

6.19 Oct 19, 2023: Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results

6.20 Oct 18, 2023: NeoDyne Launches New UK Headquarters to Mark Growth and Expansion in the UK

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

Tissue Sealants – Pipeline Products by Stage of Development

Tissue Sealants – Pipeline Products by Segment

Tissue Sealants – Pipeline Products by Territory

Tissue Sealants – Pipeline Products by Regulatory Path

Tissue Sealants – Pipeline Products by Estimated Approval Date

Tissue Sealants Companies – Pipeline Products by Stage of Development

Tissue Sealants – Pipeline Products by Stage of Development

Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview

Next Generation Internal Fixation And Sealant Device – Product Status

Next Generation Internal Fixation And Sealant Device – Product Description

Aleo BME Inc Pipeline Products & Ongoing Clinical Trials Overview

Dural Sealant – Product Status

Dural Sealant – Product Description

Surgical Sealant – Product Status

Surgical Sealant – Product Description

Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

Hemaseel HMN Fibrin Sealant – Product Status

Hemaseel HMN Fibrin Sealant – Product Description

Arch Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

AC5 Surgery – Sealant – Product Status

AC5 Surgery – Sealant – Product Description

Arizona State University Pipeline Products & Ongoing Clinical Trials Overview

Laser-Activated Nanosealant – Product Status

Laser-Activated Nanosealant – Product Description

Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview

Tisseel Dura – Product Status

Tisseel Dura – Product Description

Biomedica Management Corp Pipeline Products & Ongoing Clinical Trials Overview

ClotBlock – Product Status

ClotBlock – Product Description

Boston University Pipeline Products & Ongoing Clinical Trials Overview

Hydrogel-Based Aerosolized Sealant Dressing – Product Status

Hydrogel-Based Aerosolized Sealant Dressing – Product Description

Calmare Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

Wound Sealant – Product Status

Wound Sealant – Product Description

Clemson University Pipeline Products & Ongoing Clinical Trials Overview

Surgical Adhesive Hydrogel – Product Status

Surgical Adhesive Hydrogel – Product Description

Cohera Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

Sylys Surgical Sealant – Drug Delivery – Product Status

Sylys Surgical Sealant – Drug Delivery – Product Description

Sylys Surgical Sealant – Hernia Mesh Fixation – Product Status

Sylys Surgical Sealant – Hernia Mesh Fixation – Product Description

Sylys Surgical Sealant – Orthopedic – Product Status

Sylys Surgical Sealant – Orthopedic – Product Description

Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Covabond – Product Status

Covabond – Product Description

CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview

Progel Dural Sealant – Product Status

Progel Dural Sealant – Product Description

Progel Emerald – Product Status

Progel Emerald – Product Description

ProGEL-VS – Product Status

ProGEL-VS – Product Description

Tissue Adhesive – Product Status

Tissue Adhesive – Product Description

Tridyne Peripheral – Product Status

Tridyne Peripheral – Product Description

Department of Biomedical Engineering Columbia University Pipeline Products & Ongoing Clinical Trials Overview

Biomimetic Lung Sealant – Product Status

Biomimetic Lung Sealant – Product Description

DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview

Dural Membrane Sealant – Product Status

Dural Membrane Sealant – Product Description

Elastagen Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

MeTro – Surgical Glue – Product Status

MeTro – Surgical Glue – Product Description

Empa Pipeline Products & Ongoing Clinical Trials Overview

Polymer Patch – Product Status

Polymer Patch – Product Description

Ethicon Endo-Surgery Inc Pipeline Products & Ongoing Clinical Trials Overview

Bioseal Next Gen Device – Product Status

Bioseal Next Gen Device – Product Description

Gamma Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

GammaSeal – Product Status

GammaSeal – Product Description

GATT Technologies BV Pipeline Products & Ongoing Clinical Trials Overview

GATT-Spray – Product Status

GATT-Spray – Product Description

GATT-Tape – Product Status

GATT-Tape – Product Description

Hemostasis LLC Pipeline Products & Ongoing Clinical Trials Overview

Advanced Tissue Sealant – Product Status

Advanced Tissue Sealant – Product Description

HyperBranch Medical Technology Inc Pipeline Products & Ongoing Clinical Trials Overview

Adherus Vascular Sealant – Product Status

Adherus Vascular Sealant – Product Description

Tissue Plane Sealant – Product Status

Tissue Plane Sealant – Product Description

Institute of Molecular Biology of Parana Pipeline Products & Ongoing Clinical Trials Overview

Recombinant Fibrin Glue – Product Status

Recombinant Fibrin Glue – Product Description

InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview

InVivoSeal – Product Status

InVivoSeal – Product Description

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview

Chondroitin Sulfate-based Adhesive – Product Status

Chondroitin Sulfate-based Adhesive – Product Description

Kollodis BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview

Hemostat Sealant – Product Status

Hemostat Sealant – Product Description

Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview

KUR – 211 – Product Status

KUR – 211 – Product Description

KUR – 212 – Product Status

KUR – 212 – Product Description

Laser Tissue Welding, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Laser Tissue Welding Device – Product Status

Laser Tissue Welding Device – Product Description

Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

PTMC Sealant – Product Status

PTMC Sealant – Product Description

Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

PeriTi – Product Status

PeriTi – Product Description

Nurami Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview

ArtiFix – Product Status

ArtiFix – Product Description

NovaFibreX – Product Status

NovaFibreX – Product Description

Pharming Group NV Pipeline Products & Ongoing Clinical Trials Overview

Recombinant Fibrin Tissue Sealant – Product Status

Recombinant Fibrin Tissue Sealant – Product Description

Polyganics BV Pipeline Products & Ongoing Clinical Trials Overview

ACTISEAL – Product Status

ACTISEAL – Product Description

ACTISEAL – Adjacent Indications – Product Status

ACTISEAL – Adjacent Indications – Product Description

LIQOSEAL – Dura Sealing Patch – Product Status

LIQOSEAL – Dura Sealing Patch – Product Description

LIQOSEAL – Spine Application – Product Status

LIQOSEAL – Spine Application – Product Description

Protein Polymer Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Surgical Tissue Sealant – Product Status

Surgical Tissue Sealant – Product Description

Purdue University Pipeline Products & Ongoing Clinical Trials Overview

Surgical Sealant – Product Status

Surgical Sealant – Product Description

Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview

Surgical Sealant – Product Status

Surgical Sealant – Product Description

SCL Science Inc Pipeline Products & Ongoing Clinical Trials Overview

Surgical Sealant Film – Product Status

Surgical Sealant Film – Product Description

Sea Run Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview

SEA-STAT CNS – Product Status

SEA-STAT CNS – Product Description

Sealantis Ltd. Pipeline Products & Ongoing Clinical Trials Overview

Seal-G – Product Status

Seal-G – Product Description

Seal-G MIST – Product Status

Seal-G MIST – Product Description

Sealantis Tissue Adhesive – Product Status

Sealantis Tissue Adhesive – Product Description

Sealonix Inc Pipeline Products & Ongoing Clinical Trials Overview

PramStat Patch – Product Status

PramStat Patch – Product Description

Selio Medical Pipeline Products & Ongoing Clinical Trials Overview

Selio Sealant System – Product Status

Selio Sealant System – Product Description

Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Fibrin Sealant Powder – Product Status

Fibrin Sealant Powder – Product Description

Surgical Sealants, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Thorex – Product Status

Thorex – Product Description

Teijin Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview

KTF-374 Fibrin Sealant – Product Status

KTF-374 Fibrin Sealant – Product Description

Terasaki Institute for Biomedical Innovation Pipeline Products & Ongoing Clinical Trials Overview

Gelatin-Based Surgical Sealant – Product Status

Gelatin-Based Surgical Sealant – Product Description

Tetratherix Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

TrimphSeal – Product Status

TrimphSeal – Product Description

Texas A&M Engineering Experiment Station Pipeline Products & Ongoing Clinical Trials Overview

Biopsy Tract Sealing Device – Product Status

Biopsy Tract Sealing Device – Product Description

Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview

Tissue Welding Device – Product Status

Tissue Welding Device – Product Description

Wound Healing And Tissue Repair Bandage – Product Status

Wound Healing And Tissue Repair Bandage – Product Description

The Medicines Co Pipeline Products & Ongoing Clinical Trials Overview

Prevent GI Sealant – Product Status

Prevent GI Sealant – Product Description

Tissium SA Pipeline Products & Ongoing Clinical Trials Overview

Drug-Eluting Adhesive – Chronic Rhinosinusitis – Product Status

Drug-Eluting Adhesive – Chronic Rhinosinusitis – Product Description

SETALUM Sealant – Product Status

SETALUM Sealant – Product Description

University of Akron Pipeline Products & Ongoing Clinical Trials Overview

Wound Closure Glue – Product Status

Wound Closure Glue – Product Description

Glossary

Figures

Tissue Sealants – Pipeline Products by Stage of Development

Tissue Sealants – Pipeline Products by Segment

Tissue Sealants – Pipeline Products by Territory

Tissue Sealants – Pipeline Products by Regulatory Path

Tissue Sealants – Pipeline Products by Estimated Approval Date

Frequently asked questions

Tissue Sealants Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Tissue Sealants Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Tissue Sealants Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Tissue Sealants Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.